A084110 Stock Overview
Huons Global Co., Ltd. provides medical solutions for human health in South Korea and internationally.
Huons Global Co., Ltd. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||₩17,800.00|
|52 Week High||₩61,142.86|
|52 Week Low||₩17,750.00|
|1 Month Change||-20.36%|
|3 Month Change||-15.84%|
|1 Year Change||-69.56%|
|3 Year Change||-29.43%|
|5 Year Change||-47.35%|
|Change since IPO||-19.46%|
Recent News & Updates
Is Huons Global Co., Ltd. (KOSDAQ:084110) An Attractive Dividend Stock?
Is Huons Global Co., Ltd. ( KOSDAQ:084110 ) a good dividend stock? How can we tell? Dividend paying companies with...
|A084110||KR Pharmaceuticals||KR Market|
Return vs Industry: A084110 underperformed the KR Pharmaceuticals industry which returned -38.9% over the past year.
Return vs Market: A084110 underperformed the KR Market which returned -27.4% over the past year.
|A084110 Average Weekly Movement||4.6%|
|Pharmaceuticals Industry Average Movement||4.7%|
|Market Average Movement||5.6%|
|10% most volatile stocks in KR Market||10.5%|
|10% least volatile stocks in KR Market||3.3%|
Stable Share Price: A084110 is not significantly more volatile than the rest of KR stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: A084110's weekly volatility (5%) has been stable over the past year.
About the Company
Huons Global Co., Ltd. provides medical solutions for human health in South Korea and internationally. The company offers oral solid form products in the areas of circulatory system, metabolic, anti-pyretic analgesic anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, other chemotherapeutic, and others; and injections in the areas of anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistamine, adrenocortical hormone, enzyme, mineral, solvent, calcium, hemostatic, antidote, antibiotic, metabolic, hyaluronic acid, well-being, anticoagulant, and others, as well as circulatory, respiratory, and other tissue cell systems. It also provides medical devices, eye drop products, and bio products.
Huons Global Co., Ltd. Fundamentals Summary
|A084110 fundamental statistics|
Is A084110 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|A084110 income statement (TTM)|
|Cost of Revenue||₩282.43b|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-148.04|
|Net Profit Margin||-0.29%|
How did A084110 perform over the long term?See historical performance and comparison